On March 7, 2017, Anne Schuchat, MD (RADM, USPHS), acting director of the Centers for Disease Control and Prevention (CDC), presented at the U.S. Capitol about the need for continued action and investment to contain and address the urgent threat of antibiotic resistance.
Dr. Schuchat and experts from Infectious Diseases Society of America (IDSA), National Institutes of Health, Department of Defense and Biomedical Advanced Research and Development Authority, reminded attendees that antibiotic resistance threatens every person as well as our access to modern medicine such as cancer care and surgery. Patients like Brianna Strand, who shared her personal story about her cystic fibrosis treatment, need effective antibiotics to continue receiving life-saving treatments.
With the emergence of new threats, like Candida auris and mcr-1, combating antibiotic resistance remains a CDC priority. Dr. Schuchat described the AR Solutions Initiative and the CDC strategy to rapidly detect, contain, and prevent these infections. She called for a unified approach for a full response to protect Americans from this threat.
The Hill Briefing event was hosted by IDSA, in collaboration with the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR). IDSA, with support from several S-FAR member organizations, also released Faces of Antimicrobial Resistance—the important and personal stories of patients and their families who battle the threat of antibiotic resistance every day.
More from CDC:
Resources and tools for School Nurses and Health Educators are on our Antibiotic Resistance web page here.